The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabien Tech. Regulatory News (SNT)

Share Price Information for Sabien Tech. (SNT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12.50
Bid: 12.00
Ask: 13.00
Change: 0.00 (0.00%)
Spread: 1.00 (8.333%)
Open: 12.50
High: 12.50
Low: 12.50
Prev. Close: 12.50
SNT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Fundraise and appointment of sole broker

26 Mar 2018 07:00

RNS Number : 8391I
Sabien Technology Group PLC
26 March 2018
 

FOR IMMEDIATE RELEASE

26 March 2018

Sabien Technology Group plc

 ("Sabien" or the "Company")

 

GBP400,000 Fundraise at Premium

Appointment of Sole Broker

Director's Dealings

Total Voting Rights

 

 

Sabien Technology Group plc is pleased to announce that Peterhouse Corporate Finance Limited has raised gross proceeds of £400,000 via the placing of 80,000,000 new ordinary shares (the "Placing Shares") with new and existing investors, at a price of 0.5 pence (the "Placing Price") per Placing Share (the "Placing"). The Placing has been completed at a 25 per cent. premium to the closing mid-market price on 22 March 2018 of 0.4 pence.

 

Appointment of Broker

 

Sabien is also pleased to announce that it has appointed Peterhouse Corporate Finance Limited as Sole Broker to the Company, effective immediately.

 

Admission of the Placing Shares

 

Once issued, the Placing shares will rank pari passu with the Company's existing ordinary shares. Application will be made for the Placing Shares to be admitted to trading on AIM ("Admission") and it is expected that such Admission will become effective on or around 29 March 2018.

 

Director's Participation

 

A Director has agreed to subscribe for Placing Shares in the Placing at the Placing Price as per the table below (the "Director's Participation"):

 

 

Director

Number of Ordinary Shares pursuant to Placing

Beneficial shareholding following Placing

Percentage of Ordinary Shares as enlarged by the Placing

Bruce Gordon - Chairman

14,768,479

44,768,479

23.54%

 

B. Gordon is also a director of Thames Valley Capital Limited, an advisor to TVI 2 Limited, which holds 4,108,356 ordinary shares in the Company. He is therefore interested, directly and indirectly, in 48,876,835 Ordinary shares, representing 25.69% of the enlarged issued share capital.

 

The Director's Participation as set out above ("the Transaction") is a related party transaction under the AIM Rules. The Directors, independent of the Transaction, consider, having consulted with the Company's Nominated Adviser, that the terms of the Transaction are fair and reasonable so far as shareholders of the Company are concerned.

 

 

 

 

Total Voting Rights

 

Following Admission, there will be 190,254,867 Ordinary Shares in issue. The figure of 190,254,867 Ordinary Shares may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Sabien under the Disclosure and Transparency Rules.

 

The following information relating to the transaction has been filed with the FCA in accordance with Article 19(1) of the Market Abuse Regulation,

 

Bruce Gordon

1

Details  of  the  person  discharging  managerial  responsibilities  /  person  closely associated

a)

Name

Bruce Gordon

 

2

Reason for notification

a)

Position / status

Chairman

 

b)

Initial notification

/Amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Sabien Technology Group plc

 

b)

LEI

213800S5QG1SMGHFHY68

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description  of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 0.1 pence each in Sabien Technology Group plc

 

 

GB00B1FPCD38

 

Nature of the transaction

Purchase of ordinary shares

c)

Price(s) and volumes(s)

 

Price(s)

Volumes(s)

0.4pence

14,768,479

 

 

d)

Aggregated information

n/a

e)

Date of the transaction

23 March 2018

f)

Place of the transaction

LSE, AIM (XLON)

 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014.

 

For further information: 

Sabien Technology Group plc

+44(0)20 7993 3700

 

Alan O'Brien

 

 

Beaumont Cornish Limited (Nominated Advisor)

 +44(0)20 7628 3396

 

Michael Cornish and Roland Cornish

www.beaumontcornish.com

 

 

Peterhouse Corporate Finance Limited (Sole Broker)+44 (0) 20 7469 0930

Martin Lampshire and Fungai Ndoro

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEZMGZFKKVGRZM
Date   Source Headline
28th Mar 20242:30 pmRNSDirector/PDMR Shareholding
8th Mar 20247:00 amRNSHolding(s) in Company
6th Mar 20247:00 amRNSHolding(s) in Company
5th Mar 202411:52 amRNSHolding(s) in Company
29th Feb 20245:00 pmRNSTotal Voting Rights
21st Feb 202411:27 amRNSResult of Broker Option, Issue of Equity and TVR
20th Feb 20243:45 pmRNSDirector/PDMR Shareholding
19th Feb 20247:45 amRNSPlacement and Broker Option
19th Feb 20247:30 amRNSHalf-year Report for the 6 months to 31 Dec 2023
7th Feb 20247:00 amRNSNew system installed at Hampton Court Palace
9th Jan 20247:00 amRNSTrading Update
29th Nov 20231:00 pmRNSResult of AGM
29th Nov 20237:30 amRNSAGM Statement
21st Nov 20231:30 pmRNSHolding(s) in Company
3rd Nov 20234:50 pmRNSHolding(s) in Company
2nd Nov 20231:34 pmRNSHolding(s) in Company
2nd Nov 20237:00 amRNSFinal Results & Annual Report & Accounts for 2023
1st Nov 20237:15 amRNSUpdate on 2023 Audited Accounts
4th Oct 20237:00 amRNSM2G Rollout in US
26th Sep 20237:00 amRNSProton Technologies
22nd Sep 20236:00 pmRNSHolding(s) in Company
6th Jul 20237:00 amRNSTrading Update
8th Jun 20237:00 amRNSM2G Business Update
16th May 20237:00 amRNSFurther update on b.grn and related matters
17th Apr 20237:00 amRNSUpdate on b.grn
13th Apr 20239:15 amRNSHolding(s) in Company
6th Apr 20237:00 amRNSDirector/PCA Shareholding
5th Apr 20235:00 pmRNSDirector/PDMR Shareholding
31st Mar 20237:00 amRNSInterim Results for the 6 months to 31 Dec 2022
28th Mar 20237:00 amRNSMaterial M2G Order & Business Update
27th Mar 20237:00 amRNSM2G supports Empiric on net zero goals
10th Mar 202311:33 amRNSHolding(s) in Company
10th Mar 202311:30 amRNSHolding(s) in Company
10th Mar 20237:00 amRNSMaterial M2G order and M2G trading update
28th Feb 20232:45 pmRNSHolding(s) in Company
6th Feb 20234:30 pmRNSHolding(s) in Company
2nd Feb 20234:51 pmRNSHolding(s) in Company
22nd Nov 202212:00 pmRNSResult of AGM
22nd Nov 20227:30 amRNSInvestor Update & Annual General Meeting Statement
18th Nov 20221:46 pmRNSHolding(s) in Company
10th Nov 20227:00 amRNSInvestor Update Presentation
2nd Nov 20227:00 amRNSSupply of UK's First Regenerative Green Oil System
24th Oct 20227:00 amRNSOrder Update – New Channel Partner & Customer
17th Oct 20222:47 pmRNSHoling(s) in Company
17th Oct 20221:54 pmRNSHolding(s) in Company
17th Oct 20227:00 amRNSInternational Environmental Trae Summit Upate
17th Oct 20227:00 amRNSHoling(s) in Company
17th Oct 20227:00 amRNSInternational Environmental Trade Summit Update
17th Oct 20227:00 amRNSHolding(s) in Company
14th Oct 20227:00 amRNSFinal Results for the Year to 30 June 2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.